title: [Efficacy of pantogam in the treatment of hyperkinetic disorders in children].
abstract: We have analyzed the efficacy of nootropic drug pantogam in the treatment of hyperkinetic disorders in children aged 6-12 years. The results of the randomized placebo-controlled trial demonstrated the decrease of major symptoms of hyperkinetic disorders (inattention, hyperactivity, impulsivity), comorbid mental and behavior disorders, the improvement of cognitive functions in the group of children treated with pantogam during 6 weeks and the absence of significant changes in the placebo group. It has been concluded that pantogam is effective in the treatment of hyperkinetic disorders in children.
authors.forename: N K
authors.initials: NK
authors.lastname: Sukhotina
authors.forename: V V
authors.initials: VV
authors.lastname: Konovalova
authors.forename: I L
authors.initials: IL
authors.lastname: Kryzhanovskaia
authors.forename: T A
authors.initials: TA
authors.lastname: Kupriianova
mesh_terms: D002648:Child; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D018697:Nootropic Agents / Q000627:therapeutic use*; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018697:Nootropic Agents; C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid